Skip to content
Checked.be
Complete company report
Generated 15-08-2026
Active BE 0671.828.631Public limited company

CONVERT PHARMACEUTICALS

Esplanade Simone VEIL 1 ·4000 Liège, Belgium· 9 yrs active
Sector: Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied (72109)
Conclusion Checked

The computed 12-month bankruptcy probability of CONVERT PHARMACEUTICALS is 0.4% (very low). The company has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Based on State Gazette and CBE data.
Key figures
Active 9 yrs
Board 1
Locations 1
Publications 3
Bankruptcy probability (12 mo) Checked model v1 · free
0.4% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector −Lower-risk legal form −Higher-failure-rate region +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based
0 / 100
Low risk
Trust signals 2 signals
More than 3 years active
Founded in 2017, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags0 events
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Financial overview8 NBB filings
Financials being processed
NBB has 8 filing(s) on record for this company, latest fiscal year 2024 (volledig). The annual accounts are being processed.
Filings on record
Fiscal year Type Filed Reference
31-12-2024 volledig 26-06-2025 2025-00224144
31-12-2023 volledig 06-06-2024 2024-00115697
31-12-2022 volledig 08-06-2023 2023-00117666
31-12-2021 volledig 12-07-2022 2022-20182438
31-12-2020 volledig 22-06-2021 2021-23000593
31-12-2019 volledig 29-06-2020 2020-22200064
31-12-2018 volledig 02-07-2019 2019-26900236
31-12-2017 volledig 09-08-2018 2018-44700063
Directors & mandates 1 directors
Current directors & mandates
  • NOSHAQ Partners SRLLegal entity
    Director
    State Gazette act 26098965 (31-07-2026)
    Current
    31-07-2026 → present
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.
Legal Structure
NACE primary Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied(72109)
Legal form Public limited company(014)
Incorporation24-02-2017
StatusActive
Postal code4000
Establishment units 1 location
CONVERT PHARMACEUTICALS
Esplanade Simone VEIL 1, 4000 LiègeVervaardiging van farmaceutische grondstoffen
since 20172.262.849.157
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
62814C0006/00G002 Wallonia 6,004 m² - -
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates 11 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2026
31-07-2026
State Gazette act General meeting · Director appointment
General meeting · Director appointment
2025
26-06-2025
NBB filing Annual accounts filed
fiscal year 2024 · volledig
2024
06-06-2024
NBB filing Annual accounts filed
fiscal year 2023 · volledig
2023
08-06-2023
NBB filing Annual accounts filed
fiscal year 2022 · volledig
2022
12-07-2022
NBB filing Annual accounts filed
fiscal year 2021 · volledig
2021
22-06-2021
NBB filing Annual accounts filed
fiscal year 2020 · volledig
2020
29-06-2020
NBB filing Annual accounts filed
fiscal year 2019 · volledig
2019
02-07-2019
NBB filing Annual accounts filed
fiscal year 2018 · volledig
2018
09-08-2018
NBB filing Annual accounts filed
fiscal year 2017 · volledig
Belgian State Gazette reading coverage 1 of 11 acts read

Of the 11 Belgian State Gazette acts we know for this company, 1 has been read. The other 10 have not been read yet: what they contain is neither established nor disproved here.

Belgisch Staatsblad, acts 3 acts
Capital history · 1
07-07-2025
Capital change
All acts · 3 updated 15 days ago
2026
31-07-2026 General meeting · Officer appointment · Filing representative Open-capture extraction
  • Publication: 31/07/2026 · Convert Pharmaceuticals
  • Filing: 14/07/2026 · Convert Pharmaceuticals
  • General meeting: 01/06/2026 · Convert Pharmaceuticals
  • Officer appointment: role: administrateur, term: six ans, prenant fin à l'issue de l'assemblée générale ordinaire de 2032, start_date: 2026-06-01 · NOSHAQ Partners SRL
  • Filing representative: signer et compléter tout document et accomplir toutes les démarches nécessaires auprès des administrations et des tiers, en vue de procéder à l'ensemble des formalités requises pour la mise en oeuvre des résolutions adoptées ci-dessus et leur publication aux Annexes du Moniteur Belge, ainsi que pour procéder aux modifications auprès de la Banque Carrefour des Entreprises et des autres autorités publiques
Summary: General meeting · Officer appointment · Filing representative
Technical details 
{
  "facts": [
    {
      "date": "2026-07-31",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 31/07/2026",
      "value": "31/07/2026",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-07-14",
      "type": "filing",
      "quote": "14 JUIL. 2026",
      "value": "14/07/2026",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-06-01",
      "type": "general_meeting",
      "quote": "Extrait du proc\u00E8s-verbal de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnaires du 1er juin 2026",
      "value": "01/06/2026",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-06-01",
      "type": "officer_appointment",
      "quote": "L\u0027assembl\u00E9e nomme, (...) NOSHAQ Partners SRL, repr\u00E9sent\u00E8e par Monsieur Hugues Wallemacq, en qualit\u00E9 d\u0027administrateur. Son mandat est conf\u00E9r\u00E9 pour une dur\u00E9e de six ans, prenant fin \u00E0 l\u0027issue de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire de 2032.",
      "value": {
        "role": "administrateur",
        "term": "six ans, prenant fin \u00E0 l\u0027issue de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire de 2032",
        "start_date": "2026-06-01"
      },
      "object": "e1",
      "subject": "e2",
      "_value_raw": {
        "role": "administrateur",
        "term": "six ans, prenant fin \u00E0 l\u0027issue de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire de 2032",
        "start_date": "01/06/2026"
      }
    },
    {
      "type": "filing_representative",
      "quote": "L\u0027assembl\u00E9e d\u00E9cide \u00E0 l\u0027unanimit\u00E9 de donner mandat \u00E0 Me Adrien Lanotte, Me Antoine Clerbaux et/ou \u00E0 Me Elise Hamesse, avocats au sein du cabinet Harvest Avocats... aux fins de signer et compl\u00E9ter tout document et accomplir toutes les d\u00E9marches n\u00E9cessaires...",
      "value": "signer et compl\u00E9ter tout document et accomplir toutes les d\u00E9marches n\u00E9cessaires aupr\u00E8s des administrations et des tiers, en vue de proc\u00E9der \u00E0 l\u0027ensemble des formalit\u00E9s requises pour la mise en oeuvre des r\u00E9solutions adopt\u00E9es ci-dessus et leur publication aux Annexes du Moniteur Belge, ainsi que pour proc\u00E9der aux modifications aupr\u00E8s de la Banque Carrefour des Entreprises et des autres autorit\u00E9s publiques",
      "object": "e1",
      "subject": [
        "e5",
        "e6",
        "e7"
      ]
    }
  ],
  "act_meta": {
    "outcome": "corrected",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 2144,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0671.828.631",
      "kind": "company",
      "name": "Convert Pharmaceuticals",
      "attrs": {
        "seat": "Esplanade Simone Veil 1, 4000 Li\u00E8ge",
        "legal_form": "Soci\u00E9t\u00E9 anonyme"
      }
    },
    {
      "id": "e2",
      "kbo": null,
      "kind": "company",
      "name": "NOSHAQ Partners SRL",
      "attrs": {}
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "Hugues Wallemacq",
      "attrs": {}
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "org",
      "name": "Harvest Avocats",
      "attrs": {
        "address": "1170 Bruxelles, Boulevard du Souverain 100"
      }
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "person",
      "name": "Adrien Lanotte",
      "attrs": {}
    },
    {
      "id": "e6",
      "kbo": null,
      "kind": "person",
      "name": "Antoine Clerbaux",
      "attrs": {}
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "person",
      "name": "Elise Hamesse",
      "attrs": {}
    }
  ]
}
2025
29-08-2025 1 director appointed, 1 resigning Director changes
  • Brice Van Eeckhout, Directeur
  • Paul Tulcinsky, Directeur
Technical details 
{
  "events": [
    {
      "kind": "board_snapshot",
      "role": "bestuurder",
      "person": null,
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_out",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Paul Tulcinsky",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "death",
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-02-20",
      "evidence_quote": "Les Administrateurs prennent acte de la d\u00E9mission, en sa qualit\u00E9 d\u0027administrateur de la Soci\u00E9t\u00E9, avec effet au 20 f\u00E9vrier 2025, de Monsieur Paul Tulcinsky en raison de son d\u00E9c\u00E8s en date du 20 f\u00E9vrier 2025.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Brice Van Eeckhout",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "successor_conditional",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-05-15",
      "evidence_quote": "\u00C0 la suite du d\u00E9c\u00E8s de Monsieur Paul Tulcinsky et de la vacance d\u0027un mandat d\u0027administrateur de Soci\u00E9t\u00E9, les Administrateurs d\u00E9cident de coopter, avec effet imm\u00E9diat, Monsieur Brice Van Eeckhout.",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": "2026"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": "Paul Tulcinsky",
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "decharge_granted",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Brice Van Eeckhout",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u0027assembl\u00E9e prend acte de la d\u00E9mission, en sa qualit\u00E9 d\u0027administrateur de la Soci\u00E9t\u00E9, avec effet au 20 f\u00E9vrier 2025, de Monsieur Paul Tulcinsky en raison de son d\u00E9c\u00E8s en date du 20 f\u00E9vrier 2025.",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-08-29",
    "filing_date": "2025-08-05",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "conseil_d_administration",
      "date": "2024-11-27",
      "unanimous": null
    },
    {
      "body": "enig_aandeelhouder_schriftelijk",
      "date": "2025-07-01",
      "unanimous": null
    },
    {
      "body": "enig_aandeelhouder_schriftelijk",
      "date": "2025-05-15",
      "unanimous": true
    },
    {
      "body": "algemene_vergadering",
      "date": "2025-06-02",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0671.828.631",
    "name_full": "CONVERT PHARMACEUTICALS",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "Harvest Avocats",
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "25109962"
  ],
  "corrected_publication_numac": null
}
07-07-2025 Capital increase of €952,497 to €2,222,683 Capital & shares·Peter VAN MELKEBEKE
  • €1.270.186 → €2.222.683
Notary: Peter VAN MELKEBEKE · BruxellesFirm: Berquin Notaires
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 2222683.0,
      "delta_eur": 952497.0,
      "before_eur": 1270186.0,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": "A2",
        "n_new_shares": 276086,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "apport_nature",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_conversion",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": 1.0,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Peter VAN MELKEBEKE",
    "firm_city": null,
    "firm_name": "Berquin Notaires",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2025-07-07",
    "filing_date": "2025-07-03",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2025-06-24",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": {
    "waived": false,
    "firm_kbo": null,
    "firm_name": "CDP NICOLET \u0026 C\u00B0 SRL",
    "ibr_number": null,
    "mission_type": "apport_nature",
    "individual_name": "Jean Nicolet"
  },
  "subject_company": {
    "kbo": "0671.828.631",
    "name_full": "CONVERT PHARMACEUTICALS",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition du proc\u00E8s-verbal",
    "procuration",
    "texte coordonn\u00E9 des statuts",
    "rapport de l\u0027organe d\u0027administration",
    "rapport du r\u00E9viseur d\u0027entreprises"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 1943712,
      "class_name": "A1",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 276086,
      "class_name": "A2",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    }
  ]
}
Credit advice verdict per customer and amount

May this customer buy amount X on invoice? Enter the amount and the payment term. This page computes a GREEN, AMBER or RED verdict from them, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.
Company registry (CBE) Crossroads Bank
Activities
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72109Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72190
Primary activity highlighted.
Names & trade names
Legal nameFR CONVERT PHARMACEUTICALS
Registered office
Esplanade Simone VEIL 1
4000 Liège, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies Same sector and region · no size comparison possible · 147 of 1,175 with filed accounts
Advanced Coatings & Construction Solutions BE 0434.800.025 · Liège
ARAPONICS BE 0890.381.113 · Liège
ARTIALIS BE 0830.584.472 · Liège
Centre Belge d'Etude et d'Expertise de l'Eau BE 0402.381.833 · Liège
CENTRE DE DEVELOPPEMENT DE L'IN VITRO BE 0429.047.925 · Liège
Source: Belgian State Gazette, CBE, NBB · generated via checked.be · indicative